• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

IBM Watson, NY Genome Center to Create Open Cancer Data Repository

by Jasmine Pennic 02/26/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

IBM Watson Health

Unveiled during Thursdays’s White House Precision Medicine Initiative Summit, the New York Genome Center and IBM Watson are teaming up to create a  comprehensive and open repository of genetic data to accelerate cancer research and scale access to precision medicine. Utilizing cognitive insights from IBM Watson, the partnership could help transform the way physicians deliver personalized treatment to individual patients.

Open Cancer Data Repository Details

Together, IBM and New York Genome Center will work to build the capacity to house the contributed data, train Watson’s cognitive computing capabilities for genomic analysis and enable the Center’s member institutions and other research collaborators to sequence and analyze DNA and RNA from patients’ tumors. In phase 1 of the project, both organizations will examine genetic information from 200 cancer patients to compare how different types of sequencing might impact possible treatment options — examining whole genome and whole exome sequencing as well as clinical panels currently in wide use.

Sequencing and clinical data will be fed into Watson to accelerate and focus reviews of massive amounts of medical evidence to help identify existing drugs that may be candidates to target patients’ cancer-causing mutations. Clinically relevant insights will be returned to each individual patient’s physician to potentially support the physician’s treatment decisions. All contributed data will be maintained in a HIPAA enabled repository, in de-identified form.

Importance of Whole Genome Sequencing

Whole genome sequencing can play an important role in informing cancer research and treatment.  Access to and interpretation of this type of genomic data, however, is currently limited. By combining genetic and clinical information from patients, IBM and New York Genome Center plan to pool resources and talent while also collaborating with a variety of IBM partners and New York Genome Center members, philanthropic partners, and New York State supporters.

“Data is quickly becoming one of the most valuable resources in the fight against cancer,” said John Kelly III, PhD, Senior Vice President, Cognitive Solutions and IBM Research. “By amassing this contributed data and applying cognitive insights to the challenge of analyzing cancer data, we believe we can soon scale access to precision medicine worldwide.”

The organizations plan to raised funding from additional partners to further the expand the data repository’s growth and adoption.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Cancer Genomics, IBM Watson, IBM Watson Health, New York Genome Center, Precision Medicine Initiative

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |